Literature DB >> 10507181

Paramunity-inducing effects of vaccinia strain MVA.

B Vilsmeier1.   

Abstract

Vaccinia virus MVA is harmless for humans and animals both locally and parenterally. It offers paraspecific activities similar to those of comparable attenuated viruses of other pox genera, e.g. avipox or parapox. At the systemic level, MVA protects baby mice against lethal challenge with vesicular stomatitis virus (dose-response curve). MVA raises phagocytosis and NK-cell activity in humans and animals, whilst encouraging the induction of interferon alpha, interleukin-2 and -12 and colony-stimulating activity at the same time. The paramunity-inducing properties of MVA make it an ideal vector for the insertion of foreign genes. It is superior to other virus vectors because of its complex function. Inactivated MVA is also suitable as an inducer of paramunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507181

Source DB:  PubMed          Journal:  Berl Munch Tierarztl Wochenschr        ISSN: 0005-9366            Impact factor:   0.328


  3 in total

1.  Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.

Authors:  Ning Yang; Aitor Garcia; Cindy Meyer; Thomas Tuschl; Taha Merghoub; Jedd D Wolchok; Liang Deng
Journal:  NPJ Vaccines       Date:  2022-10-19       Impact factor: 9.399

2.  Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen.

Authors:  James W Hodge; Jack Higgins; Jeffrey Schlom
Journal:  Vaccine       Date:  2009-05-29       Impact factor: 3.641

3.  Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues.

Authors:  Motohiko Kadoki; Ashwini Patil; Cornelius C Thaiss; Donald J Brooks; Surya Pandey; Deeksha Deep; David Alvarez; Ulrich H von Andrian; Amy J Wagers; Kenta Nakai; Tarjei S Mikkelsen; Magali Soumillon; Nicolas Chevrier
Journal:  Cell       Date:  2017-09-21       Impact factor: 66.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.